Evidence map›Paper›PMID 30373235›Full record

ReviewMolecules (Basel, Switzerland)2018

Anti-Cancerous Potential of Polyphenol-Loaded Polymeric Nanotherapeutics.

Umeorah Ernest, Hai-Yan Chen, Ming-Jun Xu, Yasamin Davatgaran Taghipour, Muhammad Hassham Hassan Bin Asad, Roja Rahimi, Ghulam Murtaza

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Umeorah ErnestDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, China. isporunn@gmail.com.
Hai-Yan ChenDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, China. chenhaiyan@cpu.edu.cn.
Ming-Jun XuDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, China. mingjun_xu@stu.cpu.edu.cn.
Yasamin Davatgaran TaghipourDepartment of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz 1416663547, Iran. y.davatgaran@gmail.com.
Muhammad Hassham Hassan Bin AsadDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus 22060, Pakistan. hasshamasad@ciit.net.pk.ORCID 0000-0002-2739-9416
Roja RahimiDepartment of Traditional Pharmacy, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran 5165665931, Iran. rojarahimi@gmail.com.
Ghulam MurtazaDepartment of Pharmacy, COMSATS University Islamabad, Lahore Campus 54600, Pakistan. gmdogar356@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence has extensively demonstrated the anticancer potential of nutraceuticals, including plant polyphenols. Polymeric nanocarrier systems have played an important role in improving the physicochemical and pharmacological properties of polyphenols, thus ameliorating their therapeutic effectiveness. This article summarizes the benefits and shortcomings of various polymeric systems developed for the delivery of polyphenols in cancer therapy and reveals some ideas for future work.

Indexed as

Theranostic NanomedicineAnimalsAntineoplastic Agents, PhytogenicDrug CarriersDrug CompoundingDrug Delivery SystemsHumansNanoparticlesNanostructuresNeoplasmsPolymersPolyphenolsAntineoplastic Agents, PhytogenicDrug CarriersPolymersPolyphenolscancer therapeuticscell linesnanoparticlespolymeric carrierspolyphenols

Identifiers

PMID30373235
PMCPMC6278361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.